Quantcast

Latest Anticoagulants Stories

2012-04-25 20:20:59

Some patients with irregular heartbeats who are taken off anti-clotting medication face a high risk of stroke or blood clotting within a month, according to new research presented at the American Heart Association's Emerging Science Series webinar. Patients with certain types of atrial fibrillation, or irregular heartbeat, take these drugs to reduce the risks of clots that could lead to a stroke. Sometimes they are instructed to stop taking the medication temporarily before surgery or...

2012-04-01 23:00:11

Blau, Brown & Leonard, LLC is a national law firm based in New York City that has a hotline (800) 9100-LAW set up to speak with individuals allegedly injured by Pradaxa, also known as dabigatran etexilate mesylate. If you or a loved one took Pradaxa and had internal bleeding you can speak with an attorney 24/7 by calling (800) 910-0529. New York, New York (PRWEB) March 31, 2012 In December of 2011, The U.S. Food and Drug Administration (FDA) issued a safety announcement,...

2012-03-27 13:46:59

A review of clinical trials comparing warfarin with other medications for stroke prevention suggests that warfarin was associated with a low risk of stroke or non-central nervous system embolism in patients with nonvalvular atrial fibrillation (rapid, irregular heart beat), according to a study published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals. Novel (new) antithrombotic medications (which interfere with blood clots) have been developed as...

2012-03-26 23:44:00

Simpler regimen should facilitate initial management on outpatient basis A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism — a blockage of lung blood vessels usually caused by a clot — and showed comparable efficacy, according to data from the EINSTEIN-PE trial presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session,...

2012-03-26 12:21:56

Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle at 30 days, while a procedure that involved use of a catheter to remove the blood clot blocking that coronary artery did not produce these results, according to a study...


Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related